IRIX

IRIDEX Corporation Common Stock (IRIX)

Stock · NASDAQ · Health Care

$0.81as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 6, 2026

IRIX Completes Move of Manufacturing Facility to San Jose. Iridex has finished moving its manufacturing operations to a new facility in San Jose, California. The relocation may affect the company's production schedule as it adjusts to the new site. Investors may watch how the transition influences operating costs and supply chain efficiency.

Active signals

Resistance level
$1.02
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus

What IRIX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike58-2.9%43%
Bollinger Band Breakdown28+3.4%64%
Bollinger Band Breakout19-3.8%42%
200-Day Moving Average TouchActive now11-6.1%36%
Any 20-session window (baseline)-4.3%37%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About IRIX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight S…

Sector
Health Care
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Employees
93

Fundamentals

1-day range
$0.8126$0.922
Market cap
$14.61M
P/E (trailing)
—
P/E (forward)
Infinity
EPS (trailing)
$-0.21
Dividend yield
—
Beta
0.69
Avg. volume
391.2K
52-week range
$0.607$1.65
Next earnings: August 18, 2026 · EPS estimate $-0.01confirmed

How IRIDEX Corporation Common Stock Makes Money

Where the revenue actually goes — FY2026 annual results

market-wall.comTotalRevenue$52.67MCost of Revenue$33.45M (63%)SG&A$18.13M (34%)R&D$3.67M (7%)Tax$57.0K (0%)IRIX

Source: 10-K filed Apr 2, 2026 · via SEC EDGAR / Finnhub

Gross Profit$19.23M(37%)
Operating Income-$2.57M(-5%)

Forecasts

1 analyst ratings

Buy 86%
Hold 14%
Sell 0%
1-year price forecast
High
$2.75
+239.5%
Median
$2.75
+239.5%
Low
$2.75
+239.5%

IRIDEX Corporation Common Stock Competitors

Chosen by industry and closest market cap.

  • IRIX
    IRIDEX Corporation Common Stock
    $0.81
    ▼ 1.22%
    Market cap $14.61MP/E —
    $0.607$1.65
  • NXL
    Nexalin Technology Inc. Common Stock
    $2.35
    ▼ 4.08%
    Market cap $7.45MP/E —
    $2.38$50.7
  • NDRA
    ENDRA Life Sciences Inc. Common Stock
    $4.74
    ▼ 7.06%
    Market cap $5.68MP/E —
    $2.96$8
  • NUWE
    Nuwellis Inc. Common Stock
    $0.55
    ▲ 0.00%
    Market cap $5.26MP/E 0.03
    $0.4444$172.9
  • ITOC
    iTonic Holdings Ltd Class A Ordinary Shares
    $3.84
    ▼ 4.24%
    Market cap $4.94MP/E —
    $3.51$18.4
  • VBIO
    Valion Bio Inc. Common Stock
    $1.17
    ▼ 4.88%
    Market cap $1.14MP/E —
    $1.11$32.5
  • QTI
    QT Imaging Holdings Inc. Common Stock
    $2.4
    ▲ 0.84%
    Market cap $37.38MP/E —
    $2.38$19.05

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
636.7K
Disposed
30.6K

Institutional Ownership

March 31, 2026

Total shares held
2.83M
Total value held
$2.86M
Institutional holders
23
Top holders this quarter
  • Unknown1.00M
  • Unknown514.6K
  • Unknown396.6K
  • Unknown259.6K
  • Unknown160.2K
  • Unknown60.9K
  • Unknown57.5K
  • Unknown55.3K
  • Unknown47.4K
  • Unknown44.7K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.